European Patent Office

T 0254/93 (Prevention of skin atrophy) du 14.05.1997

Identifiant européen de la jurisprudence
ECLI:EP:BA:1997:T025493.19970514
Date de la décision
14 mai 1997
Numéro de l'affaire
T 0254/93
Requête en révision de
-
Numéro de la demande
87309681.2
Classe de la CIB
A61K 31/57
Langue de la procédure
Anglais
Distribution
Publiées au Journal officiel de l'OEB (A)
Téléchargement
Décision en anglais
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
Prévention de l'atrophie de la peau induite par les gluco- corticoides
Nom du demandeur
ORTHO PHARMACEUTICAL
Nom de l'opposant
-
Chambre
3.3.02
Sommaire

When a second medical indication is claimed in relation with a constiuent in the preparation of a known composition and the final effect is apparent in using the known composition for the known purpose, a technical problem can be seen neither in the obtention of the final effect nor in the preparation of the composition. The only remaining question could be the explanation of the phenomenon underlying the treatment according to the known process (see reasons pt. 4.4).

The mere explanation of an effect obtained when using a compound in a known composition, even if the effect was not known to be due to this compound in the known composition, cannot confer novelty to a known process if the skilled person was already aware of the occurrence of the desired effect (see reasons pt. 4.8).

Mots-clés
Novelty (no)
Novel use as a technical feature respectively technical effect within the meaning of G 2/88 denied - effects tied up and both apparent from prior use
Exergue
-

ORDER

For these reasons it is decided that:

1. The appeal is dismissed.

2. The requests for reimbursement of the appeal fee and for referral to the Enlarged Board of Appeal are refused.